CID 49843517

Lusutrombopag

Structural Information

Molecular Formula
C29H32Cl2N2O5S
SMILES
CCCCCCO[C@@H](C)C1=CC=CC(=C1OC)C2=CSC(=N2)NC(=O)C3=CC(=C(C(=C3)Cl)/C=C(\C)/C(=O)O)Cl
InChI
InChI=1S/C29H32Cl2N2O5S/c1-5-6-7-8-12-38-18(3)20-10-9-11-21(26(20)37-4)25-16-39-29(32-25)33-27(34)19-14-23(30)22(24(31)15-19)13-17(2)28(35)36/h9-11,13-16,18H,5-8,12H2,1-4H3,(H,35,36)(H,32,33,34)/b17-13+/t18-/m0/s1
InChIKey
NOZIJMHMKORZBA-KJCUYJGMSA-N
Compound name
(E)-3-[2,6-dichloro-4-[[4-[3-[(1S)-1-hexoxyethyl]-2-methoxyphenyl]-1,3-thiazol-2-yl]carbamoyl]phenyl]-2-methylprop-2-enoic acid
Related CIDs

2D Structure

compound 2d structure
5
Annotation Hits

54
References

210
Patents

590.14087 Da
Monoisotopic Mass

7.7
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 591.14815 241.2
[M+Na]+ 613.13009 251.8
[M+NH4]+ 608.17469 244.8
[M+K]+ 629.10403 244.7
[M-H]- 589.13359 243.8
[M+Na-2H]- 611.11554 244.4
[M]+ 590.14032 244.2
[M]- 590.14142 244.2
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe